Rising Demand For Targeted Therapies Drives Growth In Nanotechnology-Based Cancer Treatment Due To Their Precision In Attacking Cancer Cells: The Driving Engine Behind Nanotechnology In Cancer Treatment Market Evolution in 2025

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Nanotechnology In Cancer Treatment Market Size Growth Forecast: What to Expect by 2025?
The size of the market for nanotechnology in cancer treatments has witnessed a significant increase lately. The market, valued at $137.90 billion in 2024, is expected to reach $159.09 billion in 2025 with a CAGR of 15.4%. The market progression in the earlier period is primarily due to an increase in global cancer cases, an enhanced awareness of early cancer detection, higher investments in nanomedicine R&D, an uptick in adoption of minimally invasive procedures, and a boost in government funding for nanotechnology in oncology research.

How Will the Nanotechnology In Cancer Treatment Market Size Evolve and Grow by 2029?
The market size for nanotechnology implemented in cancer care is projected to experience significant expansion in the upcoming years, reaching a robust total of $278.07 billion by 2029 with a healthy 15.0% compound annual growth rate (CAGR). Various reasons fuel this growth in the predicted period, including an increased demand for specific cancer treatments, significant integration of nanotechnology in medication delivery systems, a heightened focus on individualized cancer treatment, growing numbers of clinical trials regarding nano-assisted cancer medication, and increased acceptance of nanotheranostics within cancer treatment. Key market trends during this prediction period involve advancements in nanotech drug delivery platforms, innovations in cancer-focused nanocarriers, merging AI with nanotechnology to enhance precision in cancer treatment, the creation of multifunctional nano-gadgets for both diagnosis and therapy, and the broadening application of nanotheranostics in custom-made medicine.

View the full report here:
https://www.thebusinessresearchcompany.com/report/nanotechnology-in-cancer-treatment-global-market-report

What Drivers Are Propelling the Growth of Nanotechnology In Cancer Treatment Market Forward?
The surge in demand for specialized cancer treatments is anticipated to accelerate the expansion of nanotechnology in the cancer treatment market. These specialized treatments, known as targeted therapies, specifically focus on molecular markers or pathways that contribute to cancer growth and progression. The preference for targeted therapies is increasing due to their precise cancer cell targeting, which reduces damage to healthy tissue and minimizes side effects. The use of nanotechnology in cancer treatment augments targeted therapies by allowing for the accurate delivery of medications directly to cancer cells, which enhances efficiency and reduces harm to healthy tissues. For example, in July 2023, a report by the American Society of Gene & Cell Therapy (ASGCT), a professional membership organization in the US, revealed that at the end of the first quarter of 2023, there were 247 gene therapies in Phase II. This figure experienced a 5% increase, reaching 260 by the end of the second quarter of 2023. Hence, the escalating demand for targeted therapies is stimulating the development of nanotechnology in the cancer treatment market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=27357&type=smp

What Are the Key Trends Driving Nanotechnology In Cancer Treatment Market Growth?
Leading enterprises in the nanotechnology in cancer treatment market are prioritizing the development of advanced treatments such as immunotherapy nano formulation. This cutting-edge technique utilizes nanotechnology to directly target and deliver immune-based therapies, reducing negative side effects for cancer patients and enhancing precision in treatment. Moreover, it improves drug stability, bioavailability, and the activation of the immune response. Cello Therapeutics, a prominent US biotechnology firm, made significant progress in this area by launching CE120, a comprehensive therapeutic cancer nano vaccine, in December 2023. Having received the green light from the Food and Drug Administration, it represents the inaugural clinical application of nanoparticles coated with platelet membrane to treat solid tumors. CE120 synergizes targeted drug delivery with immune system activation, aiming to eliminate tumors and inhibit their recurrence. The unique platform of nanotechnology used in CE120 optimizes both therapeutic accuracy and immune response, solidifying its position as a trailblazer in nanomedicine for cancer treatment.

What Are the Key Segments in the Nanotechnology In Cancer Treatment Market?
The nanotechnology in cancer treatment market covered in this report is segmented

1) By Nanotechnology Type: Liposomes, Dendrimers, Nanoparticles
2) By Treatment Type: Chemotherapy, Immunotherapy, Targeted Therapy, Combined Therapy Approaches, Surgery Assistance
3) By Cancer Type: Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Blood Cancer, Other Cancer Types
4) By Application: Targeted Drug Delivery, Photothermal Therapy, Radiation Therapy Enhancement, Diagnostics And Imaging, Gene Delivery Systems
5) By End-User: Hospitals, Research Institutions, Diagnostics Laboratories, Pharmaceutical Companies, Contract Research Organizations (CROs)

Subsegments:
1) By Liposomes: Conventional Liposomes, Stealth Liposomes, Cationic Liposomes, Immunoliposomes
2) By Dendrimers: Polyamidoamine Dendrimers, Polypropyleneimine Dendrimers, Peptide-Based Dendrimers, Carbosilane Dendrimers
3) By Nanoparticles: Gold Nanoparticles, Magnetic Nanoparticles, Polymeric Nanoparticles, Quantum Dots, Lipid Nanoparticles

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=27357&type=smp

Who Are the Key Players Shaping the Nanotechnology In Cancer Treatment Market's Competitive Landscape?
Major companies operating in the nanotechnology in cancer treatment market are Pfizer Inc., AstraZeneca PLC, Novartis AG, Amgen Inc., GE Healthcare Technologies Inc., Eisai Co. Ltd., Jazz Pharmaceuticals plc, Arrowhead Pharmaceuticals Inc., Nanobiotix S.A., EnGeneIC Ltd., Nanospectra Biosciences Inc., Sona Nanotech Inc., CritiTech Inc., Immix Biopharma Inc., DNA Nanobots LLC, Nanovery Limited, CytImmune Sciences Inc., NanOlogy LLC, NanoApps Medical Inc., ARIZ Precision Medicine.

What Geographic Markets Are Powering Growth in the Nanotechnology In Cancer Treatment Market?
North America was the largest region in the nanotechnology in cancer treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the nanotechnology in cancer treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=27357

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.